Nellie K. Owen

Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells.

Timothy J. Hoffman, Hariprasad Gali, Charles J. Smith et al. · PubMed · 2003 · 154 citations

Medicine, Pharmaceutics, Pharmacology +15

Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells

Charles J. Smith, Hariprasad Gali, Gary L. Sieckman et al. · Nuclear Medicine and Biology · 2003 · 100 citations

Medicine, Nuclear Medicine, Oncology +16

Radiochemical investigations of gastrin-releasing peptide receptor-specific [(99m)Tc(X)(CO)3-Dpr-Ser-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-(NH2)] in PC-3, tumor-bearing, rodent models: syntheses, radiolabeling, and in vitro/in vivo studies where Dpr = 2,3-diaminopropionic acid and X = H2O or P(CH2OH)3.

Charles J. Smith, Gary L. Sieckman, Nellie K. Owen et al. · PubMed · 2003 · 94 citations

Medicine, Oncology, Pharmacology +17

<i>In vivo</i> evaluation of ¹⁸⁸Re‐labeled alpha‐melanocyte stimulating hormone peptide analogs for melanoma therapy

Yubin Miao, Nellie K. Owen, Donna Whitener et al. · International Journal of Cancer · 2002 · 91 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Evaluation of an (111)In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting properties.

Jianqing Chen, Zhen Cheng, Nellie K. Owen et al. · PubMed · 2001 · 89 citations

Medicine, Oncology, Pharmacology +17